Abstract
In the Member States of the European Union, there have been diverse traditions with respect to usage of medicinal plants, and different approaches were followed at the national level. In order to harmonize assessment of herbal medicinal products and to facilitate access to the market in different Member States of the European Union, a common law was enforced in the European Union. The legal framework provided a set of basic definitions, laid down the options to grant access to the market and set the basic framework to have common standards and requirements for herbal medicinal products in the European Union. A Committee on Herbal Medicinal Products (HMPC) was established at the European Medicines Agency in 2004. The most important task of the HMPC is the development of European Union monographs which recommend harmonized standard for safety and efficacy of herbal substances and preparations thereof. With respect to the existing level of evidence, monographs are addressing a well-established use or if the evidence is not sufficient a traditional use. The HMPC is an excellent model how scientific evaluation of herbal medicines can be harmonized and set accepted and science-based standards to ensure public health.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- CTD:
-
Common Technical Document
- DCP:
-
Decentralized procedure
- EC:
-
European Community
- EDQM:
-
European Directorate for Quality of Medicines & Health Care
- EMA:
-
European Medicines Agency
- GCP:
-
Good Clinical Practice
- HMPC:
-
Committee on Herbal Medicinal Products
- MLWP:
-
Working Party on Community Monographs and List Entries
- MRP:
-
Mutual Recognition Procedure
- ORGAM DG:
-
Organizational Matters Drafting Group
- Q DG:
-
Quality Drafting Group
- TCM:
-
Traditional Chinese medicine
References
Blumenthal M, Busse WR, Goldberg A, Gruenwald J et al (eds) (1998) The complete German Commission E monographs. American Botanical Council, Austin
Consolidated Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use as amended by Directive 2002/98/EC, Directive 2003/63/EC, Directive 2004/24/EC, Directive 2004/27/EC and Directive 2008/29/EC
Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use
ESCOP Monographs.1st and 2nd edition and supplements (2009). European Scientific Cooperative on Phytotherapy, editor. Georg Thieme, Stuttgart
European Medicines Agency: http://www.ema.europa.eu – Regulatory – Human medicines
European Pharmacopeia 9th edition (2016). EDQM, Strasbourg
‘Marketing Authorisation’, the Rules governing medicinal products in the European Community, notice to applicants, Volume 2A, Chapter 1; EU Pharmaceutical legislation – EudraLex Volume 1
Regulation (EC) no 726/2004 of the European Parliament and of the council of 31 March 2004 laying down community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European medicines agency
Regulation (EC) Nr. 1901/2006 of the European Parliament and of the council of 12 December 2006 on medicinal products for paediatric use
WHO monographs on selected medicinal plants. Volumes 1, 2, 3 and 4 (2009). World Health Organisation, Geneva
Conflict of Interest
The views expressed in this article are the views of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of the European Medicines Agency or one of its committees or working parties. There is no conflict of interest.
The data and figures provided are based on data available in April 2018.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Knöss, W. (2018). Current Regulatory Environment of Herbal Medicinal Products in the European Union. In: Cechinel Filho, V. (eds) Natural Products as Source of Molecules with Therapeutic Potential. Springer, Cham. https://doi.org/10.1007/978-3-030-00545-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-00545-0_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-00544-3
Online ISBN: 978-3-030-00545-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)